Activation of the aryl hydrocarbon receptor sensitises human keratinocytes for CD95L- and TRAIL-induced apoptosis

Cell Death and Disease

Volumn 3, Issue 9, 2012, Pages

  Stolpmann, K ^a   Brinkmann, J ^a   Salzmann, S ^b   Genkinger, D ^a   Fritsche, E ^c   Hutzler, C ^a   Wajant, H ^b   Luch, A ^a   Henkler, F ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Aryl hydrocarbon receptor (AhR); Benzo a pyrene; CD95; HaCaT cells; Human keratinocytes

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CASPASE 3; CASPASE 8; CYTOCHROME C; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; FAS LIGAND; GAMMA INTERFERON; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CELL VIABILITY; DNA ADDUCT; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LONG TERM EXPOSURE; MOLECULAR INTERACTION; NECROSIS; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; APOPTOSIS; ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; BETA-NAPHTHOFLAVONE; CASPASE 8; CELL LINE; CYTOCHROME P-450 CYP1A1; DNA ADDUCTS; FAS LIGAND PROTEIN; HUMANS; KERATINOCYTES; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84867206817     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.127     Document Type: Article

References (37)

1. Hall M, Grover PL. Chemical carcinogenesis and mutagenesis. In: Cooper CS, Grover PL (eds). Handbook of Experimental Pharmacology, Vol I. Springer-Verlag: Berlin, 1990, pp 327-372.
2. Luch A, Baird WM. Carcinogenic polycyclic aromatic hydrocarbons. In: McQueen CA, Roberts R (eds). Comprehensive Toxicology, Vol 14. Elsevier: Oxford, 2010, pp 85-124.
3. Zhu H, Li Y, Trush MA. Characterization of benzo[a]pyrene quinone-induced toxicity to primary cultured bone marrow stromal cells from DBA/2 mice: potential role of mitochondrial dysfunction. Toxicol Appl Pharmacol 1995; 130: 108-120.
4. Bock KW, Köhle C. The mammalian aryl hydrocarbon (Ah) receptor: from mediator of dioxin toxicity toward physiological functions in skin and liver. Biol Chem 2009; 390: 1225-1235.
5. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453: 106-109. (Pubitemid 351630329)
6. Esser C, Rannug A, Stockinger G. The aryl hydrocarbon receptor in immunity. Trends Immunol 2009; 30: 449-455.
7. Esser C. The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. Biochem Pharmacol 2009; 77: 597-607.
8. Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 2009; 77: 713-722.
9. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 2007; 446: 562-666.
10. Ko CB, Kim SJ, Park C, Kim BR, Shin CH, Choi S et al. Benzo[a]pyrene-induced apoptotic death of mouse hepatoma Hepa1c1c7 cells via activation of intrinsic caspase cascade and mitochondrial dysfunction. Toxicology 2004; 199: 35-46. (Pubitemid 38581259)
11. Kim SJ, Ko CB, Park C, Kim BR, Sung TH, Koh DH et al. p38 MAP kinase regulates benzo[a]pyrene-induced apoptosis through the regulation of p53 activation. Arch Biochem Biophys 2005; 444: 121-129. (Pubitemid 41728344)
12. Tampio M, Loikkanen J, Myllynen P, Mertanen A, Vähäkangas KH. Benzo[a]pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells. Toxicol Lett 2008; 178: 152-159.
13. Xiao H, Rawal M, Hahm ER, Singh SV. Benzo[a]pyrene-7,8-diol-9,10-epoxide causes caspase-mediated apoptosis in H460 human lung cancer cell line. Cell Cycle 2007; 6: 2826-2834. (Pubitemid 350277176)
14. Brinkmann J, Hutzler C, Trappe S, Stolpmann K, Bock U, Liebsch M et al. Comparative studies on the metabolism of benzo[a]pyrene in keratinocytes. in vitro skin models and human skin ex vivo - metabolite patterns as indicator for the metabolic capacity of skin equivalents? Skin-In-Vitro Conference Frankfurt/Main 2010.
15. Leverkus M, Trautmann A. CD95-mediated signals in the skin: going out with an (inflammatory) bang? J Invest Dermatol 2006; 126: 2364-2366. (Pubitemid 44582254)
16. Wehrli P, Viard I, Bullani R, Tschopp J, French LE. Death receptors in cutaneous biology and disease. J Invest Dermatol 2000; 115: 141-148. (Pubitemid 30637180)
17. Kalmes M, Neumeyer A, Rio P, Hanenberg H, Fritsche E, Blömeke B. Impact of the arylhydrocarbon receptor on eugenol- and isoeugenol-induced cell cycle arrest in human immortalized keratinocytes (HaCaT). Biol Chem 2006; 387: 1201-1207. (Pubitemid 44402066)
18. Sheard MA, Vojtesek B, Janakova L, Kovarik J, Zaloudik J. Up-regulation of Fas (CD95) in human p53 wild-type cancer cells treated with ionizing radiation. Int J Cancer 1997; 73: 757-762. (Pubitemid 127483076)
19. Leverkus M, Sprick MR, Wachter T, Denk A, Bröcker EB, Walczak H et al. induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2. J Invest Dermatol 2003; 121: 149-155. (Pubitemid 36900466)
20. Jansen BJ, van Ruissen F, Cerneus S, Cloin W, Bergers M, van Erp PE et al. Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes. J Invest Dermatol 2003; 121: 1433-1439. (Pubitemid 38005497)
21. Davarinos NA, Pollenz RS. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J Biol Chem 1999; 274: 28708-28715.
22. Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999; 274: 1541-1548.
23. Siegmund D, Wicovsky A, Schmitz I, Schulze-Osthoff K, Kreuz S, Leverkus M et al. Death receptor-induced signalling pathways are differentially regulated by g-interferon upstream of caspase 8 processing. Mol Cell Biol 2005; 25: 6363-5379.
24. Kreuz S, Siegmund D, Scheurich P, Wajant H. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signalling. Mol Cell Biol 2001; 21: 3964-3973. (Pubitemid 32476458)
25. Levine-Fridman A, Chen L, Elferink CJ. Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity. Mol Pharmacol 2004; 65: 461-469. (Pubitemid 38134275)
26. Tauchi M, Hida A, Negishi T, Katsuoka F, Noda S, Mimura J et al. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol Cell Biol 2005; 25: 9360-9368. (Pubitemid 41507837)
27. Ikuta T, Namiki T, Fujii-Kuriyama Y, Kawajiri K. AhR protein trafficking and function in the skin. Biochem Pharmacol 2009; 77: 588-596.
28. Ehrenschwender M, Wajant H. The role of FasL and Fas in health and disease. Adv Exp Med Biol 2009; 647: 64-93.
29. Kerstan A, Leverkus M, Trautmann A. Effector pathways during eczematous dermatitis: where inflammation meets cell death. Exp Dermatol 2009; 18: 893-899.
30. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 2010; 5: 35.
31. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490-493. (Pubitemid 28483679)
32. Park KT, Mitchell KA, Huang G, Elferink CJ. The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis. Mol Pharmacol 2005; 67: 612-622. (Pubitemid 40365308)
33. Ndozangue-Touriguine O, Sebbagh M, Mérino D, Micheau O, Bertoglio J, Bre'ard J. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Oncogene 2008; 27: 6012-6022.
34. Iordanov MS, Sundholm AJ, Simpson EL, Hanifin JM, Ryabinina OP, Choi RJ et al. Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitis. J Invest Dermatol 2005; 125: 134-412.
35. Farley SM, Dotson AD, Purdy DE, Sundholm AJ, Schneider P, Magun BE et al. Fas ligand elicits a caspase-independent proinflammatory response in human keratinocytes: implications for dermatitis. J Invest Dermatol 2006; 126: 2438-151.
36. Farley SM, Purdy DE, Ryabinina OP, Schneider P, Magun BE, Iordanov MS. Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis. Recruitment of the epidermal growth factor receptor and activation of MAP kinases. J Biol Chem 2008; 283: 919-928.
37. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK et al. The CD95 receptor: apoptosis revisited. Cell 2007; 129: 447-450. (Pubitemid 46660984)